Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
170,450,287
-
Total 13F shares
-
83,400,028
-
Share change
-
+14,802
-
Total reported value
-
$2,083,182,434
-
Put/Call ratio
-
6.6%
-
Price per share
-
$24.99
-
Number of holders
-
154
-
Value change
-
+$449,614
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) as of Q4 2013
As of 31 Dec 2013,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value per share (ACAD) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,400,028 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Fund Advisors, VIKING GLOBAL INVESTORS LP, PRICE T ROWE ASSOCIATES INC /MD/, GILDER GAGNON HOWE & CO LLC, BlackRock Institutional Trust Company, N.A., and State Street Corp.
This page lists
154
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.